Santhera Pharmaceuticals Holding AG (0QN1.L) LSE
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CHF
Address
Hohenrainstrasse 24
Pratteln, BL 4133
Switzerland
Phone
41 61 906 89 50
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
78
First IPO Date
March 06, 2014
| Name | Title | Pay | Year Born |
| Dario Eklund | Chief Executive Officer | 1.23M | 1968 |
| Thomas Meier | Founder & Chairman | 200,000 | 1962 |
| Sarah Holmes-Klotz | Global Head of People & Culture | 0 | N/A |
| Oliver Kronenberg | Chief Legal Officer & Corporate Secretary | 0 | 1968 |
| Shabir Hasham | Chief Medical Officer | 0 | 1970 |
| Andreas Missy | Executive Vice President of Corporate Planning & Business Development | 0 | N/A |
| Catherine Ann Isted | Chief Financial Officer | 0 | 1975 |
| Oliver Strub | Head of Compliance | 0 | 1963 |
| Neville Kodkani | Head of Global Marketing & Partner Management | 0 | N/A |
| Marc Schrader | Chief Technology Officer | 0 | 1971 |
| Geert Jan van Daal | Chief Commercial Officer | 0 | 1960 |
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.